Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus.
1
式 I 的化合物是丙型肝炎病毒(HCV)RNA 依赖性 RNA 聚合酶(RdRp)
抑制剂,可用于丙型肝炎病毒感染者的治疗和预防。
1